Filing excerpt
As discussed in Note 8 to the condensed consolidated financial statements, preliminary injunctions have been awarded against the Company, prohibiting continued sales of Keytruda SC in Denmark and Italy and preventing product launches in Germany, The Netherlands, Belgium, Ireland, and France.